Vimarsana
Biggest News Aggregation in the World

Abbott Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Abbott Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Abbott Inc Today - Breaking & Trending Today

Transforming Clinical Recording of Deep Brain Activity with a New Take on Sensor Manufacturing - Vimarsana News

Transforming Clinical Recording of Deep Brain Activity with a New Take on Sensor Manufacturing

Sensors built with a new manufacturing approach are capable of recording activity deep within the brain from large populations of individual neurons--with a res

Transforming clinical recording of deep brain - Vimarsana News

Transforming clinical recording of deep brain

<p>Sensors built with a new manufacturing approach are capable of recording activity deep within the brain from large populations of individual neurons&ndash;with a resolution of as few as one or two neurons&ndash;in humans as well as a range of animal models, according to a study published in the Jan. 17, 2024 issue of the journal Nature Communications.</p>

Cereno Scientific confirms new clinic activated in the Phase II study of drug candidate CS1 in rare disease PAH - Vimarsana News

Cereno Scientific confirms new clinic activated in the Phase II study of drug candidate CS1 in rare disease PAH

Cereno Scientific , a company developing innovative treatments for common and rare cardiovascular disease, today announced that a new clinic has been activated in the ongoing Phase II study of CS1 in...

Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial | Cardiology | JAMA - Vimarsana News

Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial | Cardiology | JAMA

This randomized clinical trial examines the safety of the exclusion of aspirin as part of an antithrombotic regimen including a vitamin K antagonist with a full

C-Reactive Protein Testing Market Size to Surpass USD 3.29 Billion in 2030, at a CAGR of 5.3% - Vimarsana News

C-Reactive Protein Testing Market Size to Surpass USD 3.29 Billion in 2030, at a CAGR of 5.3%

As per the report by Fortune Business Insights, The global C-reactive protein testing market size was valued at USD 2.16 billion in 2022 and is expected to be worth USD 2.29 billion in 2023. The market is projected to reach USD 3.29 billion by 2030, recording a CAGR of 5.3% during the forecast period.Pune, India, Aug. 16, 2023 (GLOBE NEWSWIRE) -- The global C-reactive protein testing market size was valued at USD 2.16 billion in 2022 and is expected to be worth USD 2.29 billion in 2023. The mark

Source: yahoo.com